EyePoint (EYPT) Return on Sales (2010 - 2026)

EyePoint (EYPT) reported Return on Sales of 1.73% for Q1 2026, down 171.0% on a YoY basis from 2.43% in Q1 2025, and down 58.37% sequentially from 1.09% in Q4 2025.

EyePoint (EYPT) Return on Sales (2010 - 2026) Analysis & Trends

EyePoint (EYPT) has 17 years of Return on Sales data on file, last reported at 1.73% in Q1 2026.

  • For the quarter ending Q1 2026, Return on Sales fell 171.0% year-over-year to 1.73%; the trailing twelve-month figure through Mar 2026 stood at 0.4% (down 38.0% YoY), and the FY2025 full-year result was 0.07%, down 4.0% from the prior year.
  • Return on Sales fell to 1.73% in Q1 2026, from 1.09% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.01% in Q4 2023 to a low of 1.73% in Q1 2026.
  • A 5-year average of 0.24% and a median of 0.04% in 2023 frame the typical range for Return on Sales.
  • Across the five-year window, Return on Sales advanced 7 bps in 2023 and plunged 171 bps in 2026, its largest moves.
  • Tracing EYPT's Return on Sales over 5 years: stood at 0.04% in 2022, then soared by 72 bps to 0.01% in 2023, then slumped by 207 bps to 0.04% in 2024, then sank by 2952 bps to 1.09% in 2025, then sank by 58 bps to 1.73% in 2026.
  • Business Quant data shows EYPT's Return on Sales at 1.73% in Q1 2026, 1.09% in Q4 2025, and 0.62% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.00%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 0.00%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 0.00%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 0.00%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 EyePoint 358.61 Mn 136.07 Mn 168,000.00 -1.73%

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.73%
Dec 31, 2025 -1.09%
Sep 30, 2025 -0.62%
Jun 30, 2025 -0.11%
Mar 31, 2025 -0.02%
Dec 31, 2024 -0.04%
Sep 30, 2024 -0.03%
Jun 30, 2024 -0.03%
Mar 31, 2024 -0.08%
Dec 31, 2023 -0.01%
Sep 30, 2023 -0.02%
Jun 30, 2023 -0.04%
Mar 31, 2023 -0.03%
Dec 31, 2022 -0.04%
Sep 30, 2022 -0.09%
Jun 30, 2022 -0.08%
Mar 31, 2022 -0.02%
Dec 31, 2021 -0.02%
Sep 30, 2021 -0.02%
Jun 30, 2021 -0.01%